Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

16 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	702-708
Number of pages	7
Journal	British Journal of Dermatology
Volume	179
Issue number	3
DOIs	https://doi.org/10.1111/bjd.16476
Publication status	Published - 2018

Research programs

@article{bf7bf4339e1946e79af2a66f0732f16c,

title = "Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria",

author = "Tim Kanters and Bing Thio and {Hakkaart - van Roijen}, Leona",

year = "2018",

doi = "10.1111/bjd.16476",

language = "Undefined/Unknown",

volume = "179",

pages = "702--708",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria

AU - Kanters, Tim

AU - Thio, Bing

AU - Hakkaart - van Roijen, Leona

PY - 2018

Y1 - 2018

U2 - 10.1111/bjd.16476

DO - 10.1111/bjd.16476

M3 - Article

C2 - 29476533

SN - 0007-0963

VL - 179

SP - 702

EP - 708

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -